Arumugam Nagalingam

Sri Venkateshwaraa Medical College Hospital and Research Centre — India

Medicine · Health Sciences

23h-index2.1kcitations99works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phytochemicals and Medicinal Plants(35), Adipokines, Inflammation, and Metabolic Diseases(10), Cancer, Lipids, and Metabolism(10), Magnolia and Illicium research(10), Adipose Tissue and Metabolism(8)

Publications99 total

Early Experience in Lateral Intercostal Artery Perforator Flap in Oncoplastic Breast Surgery in Breast Conservation Therapy
South Eastern European Journal of Public Health·2025Open Access
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
Figshare·2024Open Access
Rare intercellular material transfer as a confound to interpreting inner retinal neuronal transplantation following internal limiting membrane disruption
Stem Cell Reports·2023· 9 citedOpen Access
Supplementary Data from A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes
2023Open Access
Supplementary Data from A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes
2023Open Access
Data from A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes
2023Open Access
Data from A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes
2023Open Access
Supplementary Figure 3 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 6 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 5 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 7 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 3 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 2 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 6 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Data from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Methods, Figure Legends from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 11 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Methods, Figure Legends from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 7 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
Supplementary Figure 5 from Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Dipali Sharma(43), Neeraj K. Saxena(33), Nethaji Muniraj(16), Sumit Siddharth(11), Panjamurthy Kuppusamy(10), Sheetal Parida(9), Balázs Győrffy(9), Jack L. Arbiser(9), Dimiter Avtanski(8), Michael Y. Bonner(6), Shivendra V. Singh(6), Panjamurthy Kuppusamy(5), Panagiotis Mistriotis(4), Κωνσταντίνος Κωνσταντόπουλος(4), Kathleen L. Gabrielson(4), Juhyung Woo(4), Marey Shriver(4), Brandi B. Knight(4), Sanjay V. Malhotra(4), Shaoguang Wu(3)